Malotilate

CAS No. 59937-28-9

Malotilate( Malotilate | CL-1500 | NKK 105 | NKK-105 )

Catalog No. M15231 CAS No. 59937-28-9

Malotilate, diisopropyl 1,3-dithiol-2-ylidenemalonate, is a drug used for the treatment of liver cirrhosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 41 In Stock
10MG 65 In Stock
25MG 82 In Stock
50MG 110 In Stock
100MG 178 In Stock
200MG 232 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Malotilate
  • Note
    Research use only, not for human use.
  • Brief Description
    Malotilate, diisopropyl 1,3-dithiol-2-ylidenemalonate, is a drug used for the treatment of liver cirrhosis.
  • Description
    Malotilate, diisopropyl 1,3-dithiol-2-ylidenemalonate, is a drug used for the treatment of liver cirrhosis.(In Vitro):Malotilate reduces collagen synthesis and cell migration activity of fibroblasts in vitro.Malotilate, an anti-fibrotic substance, selectively inhibited the 5-lipoxygenase, whereas both the 12- and the 15-lipoxygenase pathways are stimulated. Malotilate has been shown to prevent acute experimental liver injury induced by several hepatotoxic compounds, including Ahyl alcohot, Bromobenzene, Carbon tetrachloride, ChIoroform, Dimethylnitrosamine and Thioacetamide.(In Vivo):Malotilate (100 mg/kg; p.o.; daily for 3 days) treatment in rats with hypocholesterolemia results in a rapid normalization of lowered serum cholesterol.
  • In Vitro
    Malotilate reduces collagen synthesis and cell migration activity of fibroblasts in vitro.Malotilate, an anti-fibrotic substance, selectively inhibited the 5-lipoxygenase, whereas both the 12- and the 15-lipoxygenase pathways are stimulated. Malotilate has been shown to prevent acute experimental liver injury induced by several hepatotoxic compounds, including Ahyl alcohot, Bromobenzene, Carbon tetrachloride, ChIoroform, Dimethylnitrosamine and Thioacetamide.
  • In Vivo
    Malotilate (100 mg/kg; p.o.; daily for 3 days) treatment in rats with hypocholesterolemia results in a rapid normalization of lowered serum cholesterol. Animal Model:Male rats of the SLC-SD strain (rats with carbon tetrachloride-induced liver damage)Dosage:100 mg/kg Administration:P.o.; daily for 3 days Result:The triglyceride secretion from livers in rats given CCI4 was inhibited to about 40% of the level in the control rats. This inhibition of the triglyceride secretion was completely normalized in response to malotilate administration for 3 days.
  • Synonyms
    Malotilate | CL-1500 | NKK 105 | NKK-105
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    59937-28-9
  • Formula Weight
    288.38
  • Molecular Formula
    C12H16O4S2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 58 mg/mL (201.12 mM); DMSO: 58 mg/mL (201.12 mM)
  • SMILES
    O=C(OC(C)C)/C(C(OC(C)C)=O)=C1SC=CS/1
  • Chemical Name
    1,3-Dithiol-2-ylidenepropanedioic acid, bis(1-methylethyl) ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ohgoda O, et al. J Dermatol Sci, 1998, 17(2), 123-13
molnova catalog
related products
  • Lappaconine

    Lappaconine derivated from norditerpenoid alkaloids.

  • Ginsenoside Rh2

    Ginsenoside Rh2, an extract of red Panax ginseng, is a potent anti-inflammatory and anticancer drug.

  • CNP (1-22), human

    C-Type Natriuretic Peptide (CNP) (1-22), human is the 1-22 fragment of C-Type Natriuretic Peptide.